214 related articles for article (PubMed ID: 30888959)
1. Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.
Serruys PW; Tomaniak M; Chichareon P; Modolo R; Kogame N; Takahashi K; Chang CC; Spitzer E; Walsh SJ; Adlam D; Hildick-Smith D; Édes I; van de Harst P; Krackhardt F; Tijssen JGP; Rademaker-Havinga T; Garg S; Steg PG; Hamm C; Jüni P; Vranckx P; Onuma Y; Verheugt FWA
EuroIntervention; 2019 Dec; 15(12):e1090-e1098. PubMed ID: 30888959
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial.
Gao C; Tomaniak M; Takahashi K; Kawashima H; Wang R; Hara H; Ono M; Montalescot G; Garg S; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; van Geuns RJ; Hamm C; Steg PG; Onuma Y; Angiolillo DJ; Serruys PW
Cardiovasc Diabetol; 2020 Oct; 19(1):179. PubMed ID: 33066794
[TBL] [Abstract][Full Text] [Related]
3. Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
Serruys PW; Takahashi K; Chichareon P; Kogame N; Tomaniak M; Modolo R; Chang CC; Komiyama H; Soliman O; Wykrzykowska JJ; de Winter RJ; Ferrario M; Dominici M; Buszman P; Bolognese L; Tumscitz C; Benit E; Stoll HP; Hamm C; Steg PG; Onuma Y; Jüni P; Windecker S; Vranckx P; Colombo A; Valgimigli M
Eur Heart J; 2019 Aug; 40(31):2595-2604. PubMed ID: 31397487
[TBL] [Abstract][Full Text] [Related]
4. 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial.
Gamal AS; Hara H; Tomaniak M; Lunardi M; Gao C; Ono M; Kawashima H; Jüni P; Vranckx P; Windecker S; Hamm C; Steg PG; Onuma Y; Serruys PW
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):756-773. PubMed ID: 34212187
[TBL] [Abstract][Full Text] [Related]
5. Impact of renal function on clinical outcomes after PCI in ACS and stable CAD patients treated with ticagrelor: a prespecified analysis of the GLOBAL LEADERS randomized clinical trial.
Tomaniak M; Chichareon P; Klimczak-Tomaniak D; Takahashi K; Kogame N; Modolo R; Wang R; Ono M; Hara H; Gao C; Kawashima H; Rademaker-Havinga T; Garg S; Curzen N; Haude M; Kochman J; Gori T; Montalescot G; Angiolillo DJ; Capodanno D; Storey RF; Hamm C; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW; Anderson R
Clin Res Cardiol; 2020 Jul; 109(7):930-943. PubMed ID: 31925529
[TBL] [Abstract][Full Text] [Related]
6. Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERS.
de Faria AP; Modolo R; Chichareon P; Chang CC; Kogame N; Tomaniak M; Takahashi K; Rademaker-Havinga T; Wykrzykowska J; de Winter RJ; Ferreira RC; Sousa A; Lemos PA; Garg S; Hamm C; Juni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Steg PG; Serruys PW
Can J Cardiol; 2020 May; 36(5):747-755. PubMed ID: 32139280
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a pre-specified analysis of the GLOBAL LEADERS trial.
Tomaniak M; Chichareon P; Modolo R; Takahashi K; Chang CC; Kogame N; Spitzer E; Buszman PE; van Geuns RM; Valkov V; Steinwender C; Geisler T; Prokopczuk J; Sabaté M; Zmudka K; Rademaker-Havinga T; Tijssen JGP; Jüni P; Hamm C; Steg PG; Onuma Y; Vranckx P; Valgimigli M; Windecker S; Baber U; Anderson R; Dominici M; Serruys PW
EuroIntervention; 2020 Apr; 15(18):e1605-e1614. PubMed ID: 31845894
[TBL] [Abstract][Full Text] [Related]
8. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial.
Vranckx P; Valgimigli M; Jüni P; Hamm C; Steg PG; Heg D; van Es GA; McFadden EP; Onuma Y; van Meijeren C; Chichareon P; Benit E; Möllmann H; Janssens L; Ferrario M; Moschovitis A; Zurakowski A; Dominici M; Van Geuns RJ; Huber K; Slagboom T; Serruys PW; Windecker S;
Lancet; 2018 Sep; 392(10151):940-949. PubMed ID: 30166073
[TBL] [Abstract][Full Text] [Related]
9. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Ono M; Onuma Y; Kawashima H; Hara H; Gao C; Wang R; O'Leary N; Benit E; Janssens L; Ferrario M; Żurakowski A; Dominici M; Huber K; Buszman P; Garg S; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Windecker S; Vranckx P; Deliargyris EN; Bhatt DL; Storey RF; Valgimigli M; Serruys PW;
Catheter Cardiovasc Interv; 2022 Jul; 100(1):72-82. PubMed ID: 35500171
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.
Takahashi K; Serruys PW; Chichareon P; Chang CC; Tomaniak M; Modolo R; Kogame N; Magro M; Chowdhary S; Eitel I; Zweiker R; Ong P; Ottesen MM; Tijssen JGP; Wykrzykowska JJ; de Winter RJ; Garg S; Stoll HP; Hamm C; Steg PG; Onuma Y; Valgimigli M; Vranckx P; Carrie D; Windecker S
J Am Coll Cardiol; 2019 Oct; 74(16):2015-2027. PubMed ID: 31623758
[TBL] [Abstract][Full Text] [Related]
11. Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.
Hara H; van Klaveren D; Takahashi K; Kogame N; Chichareon P; Modolo R; Tomaniak M; Ono M; Kawashima H; Wang R; Gao C; Niethammer M; Fontos G; Angioi M; Ribeiro VG; Barbato E; Leandro S; Hamm C; Valgimigli M; Windecker S; Jüni P; Steg PG; Verbeeck J; Tijssen JGP; Sharif F; Onuma Y; Serruys PW;
Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006660. PubMed ID: 32762446
[TBL] [Abstract][Full Text] [Related]
12. Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design.
Kim C; Hong SJ; Shin DH; Kim BK; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am Heart J; 2019 Jun; 212():45-52. PubMed ID: 30933857
[TBL] [Abstract][Full Text] [Related]
13. Association of Sex With Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the GLOBAL LEADERS Randomized Clinical Trial.
Chichareon P; Modolo R; Kerkmeijer L; Tomaniak M; Kogame N; Takahashi K; Chang CC; Komiyama H; Moccetti T; Talwar S; Colombo A; Maillard L; Barlis P; Wykrzykowska J; Piek JJ; Garg S; Hamm C; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Mehran R; Serruys PW
JAMA Cardiol; 2020 Jan; 5(1):21-29. PubMed ID: 31693078
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).
Kawashima H; Tomaniak M; Ono M; Wang R; Hara H; Gao C; Takahashi K; Sharif F; Thury A; Suryapranata H; Walsh S; Cotton J; Carrie D; Sabate M; Steinwender C; Leibundgut G; Wykrzykowska J; de Winter RJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
Am J Cardiol; 2021 Jan; 138():1-10. PubMed ID: 33065080
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.
Ono M; Hara H; Kawashima H; Gao C; Wang R; Wykrzykowska JJ; Piek JJ; Garg S; Hamm C; Steg PG; Valgimigli M; Windecker S; Vranckx P; Onuma Y; Serruys PW
EuroIntervention; 2022 Aug; 18(5):e377-e388. PubMed ID: 35260381
[TBL] [Abstract][Full Text] [Related]
16. Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.
Valgimigli M; Gragnano F; Branca M; Franzone A; da Costa BR; Baber U; Kimura T; Jang Y; Hahn JY; Zhao Q; Windecker S; Gibson CM; Watanabe H; Kim BK; Song YB; Zhu Y; Vranckx P; Mehta S; Ando K; Hong SJ; Gwon HC; Serruys PW; Dangas GD; McFadden EP; Angiolillo DJ; Heg D; Calabrò P; Jüni P; Mehran R;
JAMA Cardiol; 2024 May; 9(5):437-448. PubMed ID: 38506796
[TBL] [Abstract][Full Text] [Related]
17. Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design.
Gao C; Zhu B; Liu J; Jiang Z; Hu T; Wang Q; Liu Y; Yuan M; Li F; Zhang R; Xia J; Onuma Y; Wang D; Serruys P; Tao L;
BMC Cardiovasc Disord; 2024 Jan; 24(1):62. PubMed ID: 38245724
[TBL] [Abstract][Full Text] [Related]
18. Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial.
Tomaniak M; Chichareon P; Onuma Y; Deliargyris EN; Takahashi K; Kogame N; Modolo R; Chang CC; Rademaker-Havinga T; Storey RF; Dangas GD; Bhatt DL; Angiolillo DJ; Hamm C; Valgimigli M; Windecker S; Steg PG; Vranckx P; Serruys PW;
JAMA Cardiol; 2019 Nov; 4(11):1092-1101. PubMed ID: 31557763
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.
Franzone A; McFadden E; Leonardi S; Piccolo R; Vranckx P; Serruys PW; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; Diletti R; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg PG; Heg D; Jüni P; Windecker S; Valgimigli M;
J Am Coll Cardiol; 2019 Nov; 74(18):2223-2234. PubMed ID: 31672177
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
Baber U; Dangas G; Angiolillo DJ; Cohen DJ; Sharma SK; Nicolas J; Briguori C; Cha JY; Collier T; Dudek D; Džavik V; Escaned J; Gil R; Gurbel P; Hamm CW; Henry T; Huber K; Kastrati A; Kaul U; Kornowski R; Krucoff M; Kunadian V; Marx SO; Mehta S; Moliterno D; Ohman EM; Oldroyd K; Sardella G; Sartori S; Shlofmitz R; Steg PG; Weisz G; Witzenbichler B; Han YL; Pocock S; Gibson CM; Mehran R
Eur Heart J; 2020 Oct; 41(37):3533-3545. PubMed ID: 33085967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
